QIM
ABBV icon

Quantitative Investment Management’s AbbVie ABBV Stock Holding History

Quantitative Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,015
Closed -$466K – 377
2025
Q3 		$466K Sell
2,015
-1,780
-47% -$362K 0.06% 240
2025
Q2 		$704K Buy
+3,795
New +$705K 0.09% 166
2025
Q1 		– Sell
-42,974
Closed -$7.64M – 319
2024
Q4 		$7.64M Sell
42,974
-31,123
-42% -$5.72M 0.57% 35
2024
Q3 		$14.6M Buy
74,097
+62,277
+527% +$11.6M 1.44% 15
2024
Q2 		$2.03M Sell
11,820
-5,429
-31% -$899K 0.22% 93
2024
Q1 		$3.14M Sell
17,249
-160,172
-90% -$27.6M 0.19% 91
2023
Q4 		$27.5M Buy
+177,421
New +$25.9M 1.58% 10
2022
Q1 		– Sell
-66,744
Closed -$9.04M – 196
2021
Q4 		$9.04M Buy
+66,744
New +$7.88M 1.27% 18
2021
Q3 		– Sell
-109,692
Closed -$12.4M – 371
2021
Q2 		$12.4M Buy
+109,692
New +$12.4M 1.12% 16
2021
Q1 		– Sell
-42,038
Closed -$4.5M – 472
2020
Q4 		$4.5M Buy
+42,038
New +$4.04M 0.36% 55
2020
Q2 		– Sell
-194,897
Closed -$14.8M – 498
2020
Q1 		$14.8M Buy
+194,897
New +$16.6M 1.62% 10
2018
Q3 		– Sell
-227,400
Closed -$21.1M – 613
2018
Q2 		$21.1M Buy
+227,400
New +$22.2M 0.44% 38
2017
Q4 		– Sell
-323,400
Closed -$28.7M – 737
2017
Q3 		$28.7M Sell
323,400
-427,400
-57% -$32.5M 0.33% 73
2017
Q2 		$54.4M Buy
750,800
+183,300
+32% +$12.3M 0.82% 11
2017
Q1 		$37M Buy
+567,500
New +$35.7M 0.56% 26
2015
Q4 		– Sell
-166,400
Closed -$9.05M – 676
2015
Q3 		$9.05M Buy
+166,400
New +$10.8M 0.68% 26
2015
Q2 		– Sell
-187,400
Closed -$11M – 432
2015
Q1 		$11M Buy
187,400
+105,300
+128% +$6.36M 1.05% 13
2014
Q4 		$5.37M Buy
+82,100
New +$5.18M 0.83% 23

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Quantitative Investment Management's ABBV Position: Q4 2025 in Review

Quantitative Investment Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 2,015 shares — an estimated $466K sold.

Quantitative Investment Management first reported a position in ABBV in Q4 2014 and held it in 18 quarters. The position peaked at $54.4M in Q2 2017. 4,146 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Quantitative Investment Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Quantitative Investment Management sold 2,015 AbbVie shares in Q4 2025, an estimated $466K.
  • Quantitative Investment Management first reported a position in AbbVie in Q4 2014 and held it in 18 quarters.
  • Quantitative Investment Management's AbbVie position peaked at $54.4M in Q2 2017.
  • 4,146 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Quantitative Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.